Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceDiamondback 360™ Coronary Orbital Atherectomy System; Diamondback 360 Precision™ Coronary Orbital Atherectomy System
Generic NameCATHETER, CORONARY, ATHERECTOMY
ApplicantCardiovascular Systems, Inc.
651 Campus Dr.
Minneapolis, MN 55211
PMA NumberP130005
Supplement NumberS051
Date Received02/13/2026
Decision Date03/10/2026
Product Code MCX 
Advisory Committee Cardiovascular
Supplement Type30-Day Notice
Supplement Reason Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review Granted? No
Combination ProductYes
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
the adoption of Abbott Vascular (AV) environmental monitoring testing procedures for Abbott Vascular Houston (AVH) and Abbott Vascular St. Paul (AVSP) facilities and to replace the current supplier for environmental monitoring testing with Abbott Vascular Temecula (AVT) and Abbott Vascular Westford (AVW) as the laboratory testing sites
-
-